Skin cancer has emerged as the fifth most commonly reported cancer in the world, causing a
burden on global health and the economy. The enormously rising environmental changes …

Nanotechnological drug delivery platforms represent a new paradigm for cancer
therapeutics as they improve the pharmacokinetic profile and distribution of …

The use of natural compounds is becoming increasingly popular among patients, and there
is a renewed interest among scientists in nature-based bioactive agents. Traditionally …

Melanoma is the most aggressive skin carcinoma and nanotechnology can bring new
options for its pharmacological treatment. Nanostructured lipid carriers (NLC) are ideal drug …

Breast cancer is the neoplasia of highest incidence in women worldwide. Docetaxel (DTX), a
taxoid used to treat breast cancer, is a BCS-class-IV compound (low oral bioavailability …

Nanostructured lipid carriers (NLCs) are typically composed of liquid lipids, solid lipids, and
surfactants, enabling the encapsulation of lipophilic drugs. Butamben is a Class II anesthetic …

Nanostructured lipid carriers (NLC) have emerged as innovative drug delivery systems,
offering distinct advantages over other lipid-based carriers, such as liposomes and solid …

Skin carcinoma remains one of the most widespread forms of cancer, and its global impact
continues to increase. Basal cell carcinoma, melanoma, and squamous cell carcinoma are …

Musculoskeletal pain is considered the most common cause of disability worldwide and has
become one of the frequent reasons for opioid prescription. The dire consequences of the …

Nanotechnology has been becoming an important part of people's daily life. Thanks to the
rapid development in the last decades, many “nano-products” are already available …